What Is the Impact of the Novel Coronavirus and the Vaccination on Guillain-Barre Syndrome?

Chen, Yinuo; Li, Kezheng; Lv, Wenjing; Xie, Jiali; Qian, Yuqin; Cui, Can; Deng, Binbin

Chen, Yinuo; Li, Kezheng; Lv, Wenjing; Xie, Jiali; Qian, Yuqin; Cui, Can; Deng, Binbin.

Afiliación

Chen Y; Department of Neurology, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Li K; First Clinical College of Wenzhou Medical University, Wenzhou, China.
Lv W; Department of Neurology, First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China.
Xie J; First Clinical College of Wenzhou Medical University, Wenzhou, China.
Qian Y; Department of Geriatrics, The Affiliated Hospital of Qingdao University, Qingdao, China.
Cui C; Department of Neurology, Shanghai East Hospital, Tongji University, Shanghai, People's Republic of China.
Deng B; Department of Neurology, Institute of Neurology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Mol Neurobiol ; 2023 Sep 20.

Article en En | MEDLINE | ID: mdl-37728848

Palabras clave

COVID-19; Clinical manifestation; Epidemiology; GBS; Vaccine

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Mol Neurobiol Asunto de la revista: BIOLOGIA MOLECULAR / NEUROLOGIA Año: 2023 Tipo del documento: Article País de afiliación: China Pais de publicación: Estados Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google